Blog

Preventing Heart Attacks in Athletes By Steve Parcell, ND NatureMed Clinic Boulder, Colorado The thought of having a sudden heart attack is so disturbing that many people don’t even consider that it could happen to them. I call this the “it can’t happen to me scenario”. Other people may say things like “my cholesterol is normal and I exercise, eat well and don’t have too much stress so I will not get a heart attack.” Well I’m here...

By Steve Parcell, ND Boulder In 2013 the big chelation study was finally published in the Journal of the American Medical Association (JAMA). The study added further data supporting chelation for heart disease, especially coronary artery disease. Chelation therapy with disodium EDTA has been used for more than 50 years to treat atherosclerosis without proof of efficacy.The objective was to determine if an EDTA-based chelation regimen reduce...

By Kelly Parcell, ND One of the greatest areas of confusion and natural medicine today, especially in Boulder, is the subject of bioidentical hormones.  Consumers, practitioners, manufacturers and the media all contribute to some of this misunderstanding.  How are bioidentical hormones different from synthetic hormones?  A bioidentical hormone is a hormone that is biochemically identical to the human hormone. You have wanted to try estrog...

By Steve Parcell, ND On January 1st marijuana became legal to purchase in Colorado with or without a medical prescription. As marijuana is now legal in Boulder I have seen I slight increase in concerns about breast enlargement (gynecomastia) in men. Speculation that men who smoke pot are prone to develop abnormal breast tissue or "man boobs" has been around for decades. The first scientific paper examining the clinical impact of the drug's a...

By Steve Parcell, ND Valsartan is a common blood pressure lowering agent that I like for it beneficail effect aging. Now there is new data on Valsartan and plaque reversal. In the  EFFERVESCENT trial researchers hypothesized that the angiotensin receptor blocker valsartan (Diovan, Novartis) would reduce carotid artery wall thickness and inhibit atherosclerotic plaque progression. The EFFERVESCENT trial included 120 participants with ca...